Katherine T. Ostapoff

Author

The University of Texas Southwestern Medical Center

Also Known As

K.T. Ostapoff, Katherine Ostapoff, Katherine T Ostapoff, Katherine T. Ostapoff

Publications

422

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Southwestern Medical Center Roswell Park Comprehensive Cancer Center

About

Katherine T. Ostapoff is an author at The University of Texas Southwestern Medical Center specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	30
2	Cancer Therapeutics	2	2	30
3	Pharmacology	1	1	12
4	Surgical Oncology	1	1	18
5	Cancer Cell Biology	1	1	12

Katherine T. Ostapoff

Publications

388

Citations

H-Index

Page 1

	Year	Citations
BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer Bercin Kutluk Cenik, Katherine T. Ostapoff, David E. Gerber, Molecular Cancer Therapeutics	2013	91
PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Molecular Cancer Therapeutics	2013	66
Neutralizing Murine TGFβR2 Promotes a Differentiated Tumor Cell Phenotype and Inhibits Pancreatic Cancer Metastasis Katherine T. Ostapoff, Bercin Kutluk Cenik, Miao Wang, Cancer Research	2014	63
Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer Amanda Kirane, Jason E. Toombs, Katherine T. Ostapoff, Clinical Cancer Research	2012	56
Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib Amanda Kirane, Jason E. Toombs, Jill E. Larsen, Carcinogenesis	2012	26
Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model Begoña Díaz, Katherine T. Ostapoff, Jason E. Toombs, Oncotarget	2016	23
Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma? Katherine T. Ostapoff, Emmanuel Gabriel, Kristopher Attwood, HPB Surgical OncologyPancreatic CancerOverall SurvivalMedicineImmune Checkpoint Inhibitor	2017	18
Disparities in the Age-Related Rates of Colorectal Cancer in the United States Emmanuel Gabriel, Katherine T. Ostapoff, Kristopher Attwood, The American Surgeon	2017	18
Axillary lymph node dissection for breast cancer utilizing Harmonic Focus® Katherine T. Ostapoff, David Euhus, Xian‐Jin Xie, World Journal of Surgical Oncology	2011	15
Comparative benefits of nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. Niranjan Awasthi, Katherine T. Ostapoff, Changhua Zhang, Journal of Clinical Oncology NanotherapeuticsExperimental Pancreatic CancerPharmacotherapyTumor BiologyPolysorbate-based Docetaxel	2013	12

Page 1